Practice Alert Podcast

Coronavirus vaccine: The contenders, the potential controversy

J Fam Pract. 2020 September;69(7):audio | 10.12788/jfp.0050
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

With COVID-19 cases in the United States exceeding 5 million, much hope is being placed on the development of a vaccine. Dr. Campos-Outcalt describes the 5 vaccine candidates currently in rapid development through Operation Warp Speed, a private/federal initiative to substantially shorten vaccine development time. He also explains the safeguards in place to reassure the public that no “shortcuts” are being taken regarding vaccine safety.

 

References

  1. CDC. Coronavirus Disease 2019 (COVID-19): Cases in the US. www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed August 18, 2020.
  2. US Department of Health and Human Services. Fact Sheet: explaining Operation Warp Speed. www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.html. Accessed August 18, 2020.
  3. O’Callahan KP, Blatz AM, Offit PA. Developing a SARS-CoV-2 vaccine at warp speed. JAMA. 2020;324:437-438.
  4. Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines—a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261-279.
  5. Lurie N, Sharfstein JM, Goodman JL. The development of COVID-19 vaccines: safeguards needed [commentary]. JAMA. 2020;324:439-440.
  6. Salman DA, Akhtar A, Mergler MJ, et al; H1N1 Working Group of Federal Immunization Safety Task Force. Immunization safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics. 2011;127(suppl 1):S78-S86.

Next Article:

FDA expands remdesivir use for all COVID-19 hospitalized patients